跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Duloxetine Hydrochloride Enteric Capsules
Approved
化学药品
Duloxetine Hydrochloride Enteric Capsules
Eli Lilly and Company
🇨🇳 National Medical Products Administration
Approval Date
Aug 6, 2024
Approval ID
8bLY6sm2ayV
Company
Eli Lilly and Company
Type
化学药品
Approval Details
Approval Id
8bLY6sm2ayV
Approval Number
国药准字HJ20150284
Generic Name
盐酸度洛西汀肠溶胶囊
Generic Name En
Duloxetine Hydrochloride Enteric Capsules
Trade Name
欣百达
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
按C₁₈H₁₉NOS 计 30mg
Reg Date
2024-08-06
Expired Date
2029-06-26
Company Name
Eli Lilly and Company
Production Company Name
Lilly Del Caribe, Inc.
Company Detail Path
/organization/eli-lilly-cdr-cad-hedged
Production Company Detail Path
/organization/lilly-del-caribe-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 6, 2024
Approval ID
8bLY6sm2ayV
Type
化学药品
Back to NMPA Approvals
欣百达 - NMPA Drug Approval Details